Trial intelligence / Profile preview

Rilpivirine and Ritonavir-boosted Darunavir in Therapy-naive HIV-1 Patients

NCT01736761Phase 4Completed

Sponsor
St Stephen's AIDS Trust
Start
Dec 2012
Primary completion
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of darunavir, rilpivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by St Stephen's AIDS Trust. Started Dec 2012; status: completed.

02

Drugs

darunavirrilpivirine
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT01736761.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01736761.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call